Condition

Optic Neuropathy

ClinicalTrials.gov condition label

Clinical trials10

Recruiting2

Common interventions15

Lead sponsors shown9

Clinical trials

10 shown

Hyperbaric Oxygen Therapy for Optic NeuropathiesNCT06128720 · 2022-11-01

Stem Cell Ophthalmology Treatment Study IINCT03011541 · 2016-01-01

Clinical Study of FB1001 in PatientsNCT06506305 · 2024-08-15

NOT_YET_RECRUITING

Effect of Intraocular Tamponade on Visual PerceptionNCT05543018 · 2022-09-12

Assessment of Visual Function With a Portable Brain-computer InterfaceNCT03760055 · 2019-02-11

Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple SclerosisNCT03536559 · 2018-11-23

BCI and Evaluation of Visual and Task Performance in Subjects With Eye DiseasesNCT03318549 · 2018-10-29

Biomechanics of Optic NeuropathyNCT02982499 · 2016-09-01

Comparing Rates of Glaucoma in Professional Wind Versus Non-Wind Instrument PlayersNCT02612571 · 2015-07-01

Use of Bevacizumab in Trabeculectomy SurgeryNCT01166594 · 2010-06-01

Common interventions

Arm 1PROCEDURE1 BevacizumabDRUG1 Brain-computer interfaceDEVICE1 CNM-Au8DRUG1 ControlDRUG1 ElectroretinogramDIAGNOSTIC_TEST1 FB1001DRUG1 Hyperbaric OxygenDEVICE1 magnetic resonance image (MRI)DEVICE1 nGoggleDEVICE1 Optical Coherence Tomography (OCT)DEVICE1 PlaceboDRUG1 Sham Hyperbaric OxygenDEVICE1 Visual Performance testsDIAGNOSTIC_TEST1 Vitrectomy operationPROCEDURE1

Leading sponsors

University of Miami2 Benha University1 Clene Nanomedicine1 MD Stem Cells1 NGoggle1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1 Stanford University1 Sunnybrook Health Sciences Centre1 Wills Eye1

Trial status mix

COMPLETED3

RECRUITING2

TERMINATED2

UNKNOWN2

NOT_YET_RECRUITING1

Phase mix

NA4

PHASE11

PHASE21

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.